Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA in Hepatic Sarcoidosis
NCT03602976Phase 2Terminated
- Start
- Aug 2018
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ursodeoxycholic acid in hepatic sarcoidosis. Started Aug 2018; status: terminated.
02
Drugs
ursodeoxycholic acid
03
Conditions
hepatic sarcoidosis
Beyond the preview
Go deeper on NCT03602976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03602976.